The tumor harbored a pathogenic ATRX pI1049fs mutation, BRAF:KIAA1549 gene fusion, monosomy of chromosome 1p and distal 19q, and trisomy of chromosome 1q. The gene discussed is BRAF; the disease is neoplasm.